Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Table of Contents	220
Sticking With It: The Continued Benefits of 2 Years of Peanut Epicutaneous Immunotherapy in Young Children	146
Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease	141
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing	108
Managing CPAP Rhinitis	106
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	99
Table of Contents	86
Respiratory Diseases Associated With Organic Dust Exposure	85
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	84
Reply to “Correspondence on ‘Neuropsychiatric events related to montelukast and pranlukast in adults with asthma and rhinitis: a 10-year nationwide population-based study’”	80
Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	78
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	78
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	76
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy	75
Information for Readers	72
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	71
March 2023 Practice Notes	68
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	67
COVID-19 Treatments: Then and Now	65
Managing Atopic Dermatitis in Patients With Skin of Color	63
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	63
Quality and Safety: Learning from the Past and (Re)Imagining the Future	62
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	62
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	62
Practice Notes from the AAAI	62

Table of Contents	58
Allergic Rash Mimickers	58
Smoking in severe asthma: Unraveling the overlap with COPD	58
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	57
Reply to “Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time”	57
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges	56
Resolution of hypereosinophilic syndrome following resection of a schwannoma	54
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?	54
Evolving Food Allergy Clinical Trials to Become More Patient-Centered	53
Assessment of Real-World Escalation to Biologics in US Patients With Asthma	53
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	50
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	50
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	47
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	47
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study	47
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	46
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	45
Disparities in Genetic Testing for Inborn Errors of Immunity	45
Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?	45
Generational Consequences From Historical Redlining: Longitudinal Impacts on Air Pollution and Asthma Health Outcomes	45
The impact of COVID-19 on a national sample of US adults with food allergy	44
Efficacy of Epinephrine Nasal Spray in the Treatment of Urticaria	44
Reply to “Correlation, causation, and confounding: How worried should we be about dementia risk and second-generation antihistamines?”	44
Gene Therapy for Inborn Errors of Immunity	44
Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting	44
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	43
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada	43
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	43
Weight Loss Interventions for Adults With Obesity-Related Asthma	42
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	42
Asthma Management in Children	42
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challenges	41
Impact of Chronic Rhinosinusitis on Long-Term Clinical Outcomes in Adults With Asthma	41
Charting the Seas of Drug Allergy	41
A Media Advocacy Toolkit for the Allergist-Immunologist	40
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction	40
Reducing Health Disparities in Asthma: How Can Progress Be Made	40
Combination of Allergen-Specific Immunotherapy With Biologics in Severe Asthma: Counterintuitive or Rational?	39
Food Oral Immunotherapy Patient Selection, Dosing, and Monitoring Practices Among a Network of US Food Allergy Centers	39
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	39
Biologic Therapy and Aspirin Reactivity in AERD: A Scoping Review.	39
Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?	39
Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial	38
Endoscopic Evaluation of Patients With Food Allergy for Eosinophilic Esophagitis Before Oral Immunotherapy	38
Diagnosis and Management of Asthma During Pregnancy	38
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	38
One Allergy, Two Paths: Navigating Penicillin Allergy Evaluation in Pregnant Patients, Direct Challenges Versus Penicillin Skin Testing in Pregnancy	38
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	38
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	38
Longitudinal Pathways Between Major Depressive Disorder and Asthma Outcomes in Older Adults	38

Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis	38
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	37
Chronic norovirus infection in immunodeficiency: A UK national case series	37
Lung Effects of Household Air Pollution	37
Understanding Health Equity in Patient-Reported Outcomes	37
Systemic Therapy for Atopic Dermatitis: Choosing Biologics or Janus Kinase Inhibitors for Children and Adults	37
Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases	36
Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials	36
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	36
Feeding difficulties in children with food protein–induced enterocolitis syndrome	36
Blue Wheals and Blue Angioedema Induced by Blue Dyes: A Systematic Review	36
Burden of Allergic Disease in Racial and Ethnic Structurally Oppressed Communities Within Canada and the United States: A Scoping Review	36
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions	36
Systemic Therapies for Atopic Dermatitis	36
Allergic bronchopulmonary aspergillosis or tropical pulmonary eosinophilia: discriminatory potential of recombinant Aspergillus fumigatus antigens	35
Editorial Board	35
Allergic Lymphangitis after Hymenoptera Sting	35
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab	35
Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease?	35
Preimplantation genetic testing for hereditary angioedema as a potential dominant cost-effective intervention	35
Sensitization is persistent in most patients with anaphylaxis to a cephalosporin at 10 years	35
Comorbid Scenarios in Contact Dermatitis: Atopic Dermatitis, Irritant Dermatitis, and Extremes of Age	35
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation	35
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse Reactions	35
Hazelnut Oral Immunotherapy Desensitizes Hazelnut But Not Other Tree Nut Allergies (Nut CRACKER Study)	34
Accelerating Food Allergy Research: Need for a Data Commons	34
Inpatient Penicillin Allergy Evaluation—Skin Testing Versus Direct Oral Challenge?	34
Does Adherence to Inhaled Corticosteroids/Long-Acting β2-Agonists Matter in Patients With Severe Asthma Receiving Biologic Therapies?	34
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or Older	34
Barriers and Enablers of Dietary Reintroduction Following Negative Oral Food Challenge: A Scoping Review	34
AIR Therapy: Improving Patient and Planetary Health	34
Cost Control Versus Optimal Patient Care in Hereditary Angioedema	33
Table of Contents	33
September 2023 Practice Notes	33
Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome	33
The Th17/IL-17 Axis and Host Defense Against Fungal Infections	33
December 2023 Practice Notes	32
Domiciliary assessment of the type 2 inflammatory FeNO type	32
Infrared-induced hives	31
CME exam: The Microbiome as a Gateway to Prevention of Allergic Disease Development	31
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility	31
Immediate adverse reactions to horse antithymocyte globulin: A 10-year single-center experience	31
Remission of indolent systemic mastocytosis in the absence of targeted therapy	31
Preparing the Allergist/Immunologist for the Next Pandemic	31
Table of Contents	30
Teleallergy: Where Have We Been and Where Are We Going?	30
Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study	30
Multiple chemical sensitivity/idiopathic environmental intolerance: A disability-rights, patient-led perspective	30
Walnut Threshold Dose Distribution and Safe Dose in Allergic Patients (Nut CRACKER Study)	30
Effect of Weight Loss on Asthma in Obese Adult Patients With Asthma: A Systematic Review and Meta-Analysis	30
Management of Mastocytosis and Mast Cell Activation in Children	30
Risk Factors and Age-Related Patterns of Asthma-Like Symptoms in Early Childhood	30
Outcomes among racial and ethnic minority groups with X-linked agammaglobulinemia from the USIDNET registry	29
The Use of Flexible Rhinolaryngoscopy for Allergy-Immunology Practice	29
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey	29
Erratum	29
Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts	29
Correction	29
Organizing pneumonia in patients on dupilumab therapy for nasal polyposis: A report of three cases	28
Acculturation and asthma in Asian American adults	28
Gender and geographically based disparities among editors and editorial board members in highly cited allergy journals	28
Disease Course of Eosinophilic Esophagitis Under Anti-inflammatory Treatment	28
Hypertension risk in patients having hereditary angioedema with plasminogen gene mutation K330E	28
Patient Perceptions of Penicillin Allergy Testing in a Public Health System	27
Clinical and diagnostic features of 33 patients with aquagenic urticaria	27
Patient Global Impression of Severity Scale in Chronic Cough: Validation and Formulation of Symptom Severity Categories	27
Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency	27
Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome	27
Oscillometry may be used to detect bronchodilator reversibility in asthma patients with preserved spirometry	27
Stability of epinephrine nasal spray under room temperature, freeze-thaw, and extreme temperature conditions	27
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort	27
Key Symptoms in Bronchial Asthma Diagnosis: Identification via Decision Tree Modeling	27
Nuts and Bolts of Relationship-Centered Communication in the Allergy Immunology Clinic	26
The Role of Maternal Diet and Supplements During Pregnancy and Lactation in the Prevention and Development of Food Allergies and Atopic Dermatitis	26
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)	26
Reply to “Omalizumab-assisted venom immunotherapy: The need for standardized qualification and protocol-dependent risk assessment”	26
Telehealth and Allergy Services in Rural and Regional Locations That Lack Specialty Services	26
The Prevalence of IgE-Mediated Food Allergy and Other Allergic Diseases in the First 10 Years: The Population-Based, Longitudinal HealthNuts Study	26
Use of Antibiotics in Infancy and Asthma in Childhood: Confounded or Causal Relationship? A Critical Review of the Literature	26
Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist	26

The Environmental Microbiome, Allergic Disease, and Asthma	26
Social Determinants and Quality of Life in Food Allergy Management and Treatment	26
Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?	26
Frequent Allergic Sensitization to Farmed Edible Insects in Exposed Employees	26
Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis	26
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	26
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis	25
Outpatient epinephrine administration reduces ICU admission rates in anaphylactic reactions: A propensity score–matched cohort	25
About the Cover: A New “Image” for In Practice	25
Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy	25
Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis	25
Factors Associated With Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System	25
Novel Connections of Common Childhood Illnesses Based on More Than 5 Million Diary Registrations From Birth Until Age 3 Years	25
Cover 1	25
Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations	25
A Community-Based Participatory Research Approach to Understanding Childhood Asthma in the Navajo Nation	25
Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective	25
Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease	25
Subcutaneous Emphysema Presenting as Bilateral Periorbital Angioedema	24
Contact Dermatitis of a Surgical Wound	24
Housing Mobility Intervention and the Impact on Pediatric Asthma Morbidity: A Novel Asthma-Directed Therapy	24
Diagnosis and Treatment Options for T2-Low Asthma	24
Cover 1	24
Original Article Highlights From This Issue	24
Challenges and Opportunities in Asthma Prevention and Treatment	24
COVID-19 and Pregnancy: Interrelationships With Asthma and Allergy	24
Exercising with Asthma: A Slow Burn or a Quick HIIT?	24
Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy	24
More Than Moderate-Dose Inhaled Corticosteroid Therapy for Difficult-to-Treat Asthma: One Step Too Many?	24
Altered Symptom Perception in Children With Asthma Is Associated With Poor Childhood Opportunity and Adverse Outcomes	24
Patient-Centered Immunotherapy: Empowering Patients With Dosing Schedule Education and Self-Tracking Modality	24
Information for Readers	24
Smoke and the Lungs	24
Comparison of Standard, Cluster, and Rush Allergy Immunotherapy Buildup Protocols	24
Pulmonary Infiltrates With Hypereosinophilia	24
Polycystic ovary syndrome and the risk of asthma in reproductive-age women: Insights from 2 real-world large cohorts	24
Information for Readers	24
Current Management of Allergic Rhinitis	24
Exfoliative Dermatitis During Antituberculosis Treatment	23
Analyzing Racial Disparities in Pediatric Atopic Comorbidity Emergency Department Visitation Using Electronic Health Records	23
Milk or egg allergy diagnosis increases the risk of eosinophilic esophagitis diagnosis	23
Fatigue in Severe Uncontrolled Asthma	23
Association between social needs and asthma control among children evaluated at a single-center high-risk asthma clinic	23
Allergic Mucin in Allergic Fungal Rhinosinusitis	23
The Art of Immunotherapy	23
Perceived high risk of COVID-19 vaccination: The revealing power of placebo	23
Oral immunotherapy in US allergy practice	23
Corrections	23
Recent Advances in the Treatment of Eosinophilic Esophagitis	23
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color	23
Risk of Self-Harm and the Use of Leukotriene Receptor Antagonists and Inhaled Corticosteroids: A Population-Based Study	23
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab	23
Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria	23
Idiopathic Anaphylaxis	22
The Art of Dosing for Subcutaneous Immunotherapy in North America	22
Cautious interpretation of dupilumab’s superiority in asthma: Methodological limitations and subgroup-specific efficacy	22
Pretreatment with ibrutinib facilitates rapid drug desensitization in a difficult case of brentuximab vedotin–induced anaphylaxis	22
Asthma Lowers the Risk of COVID Hospitalization in Children: Impact of Symptom Control Status	22
Cover 1	22
Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review	22
Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review	22
Reply to “The use of basophil activation tests (BATs) in the diagnosis of penicillin allergy”	22
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy	22
Demographic and clinical variations in pediatric eosinophilic esophagitis: Insights from a multidisciplinary clinic	22
Real-world effectiveness analysis of preschool cashew and walnut oral immunotherapy	22
Association of Asthma and Rheumatoid Arthritis: Conundrum Still Unsolved	22
Inborn Errors of Immunity: A Role for Functional Testing and Flow Cytometry in Aiding Clinical Diagnosis	22
Beyond Avoidance: Advanced Therapies for Contact Dermatitis	21
Second-Generation H1-Antihistamines Do Not Alter Dementia Risk in Type 2 Inflammatory Diseases: A Target Trial Emulation Using Real-World Data	21
Microbial Therapeutics for the Prevention and Treatment of Food Allergy	21
Environmental Injustice Is Associated With Poorer Asthma Outcomes in School-Age Children With Asthma in Metropolitan Atlanta, Georgia	21
Allergic Fungal Rhinosinusitis: Distinct Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Strategies	21
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus	21
Reply to “Challenging dated conceptions to advocate for evidence-informed care in multiple chemical sensitivity”	21
Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis	21
Efficacy and Safety of Oral Antihistamines for Allergic Rhinitis: Network Meta-Analysis	21
Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma	21
Clinical Remission in Patients With Biologic-Naïve Asthma: A Multicenter Study in Japan	21
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions	21
Asthma Burden in Mild Adult Asthma in the PEARL Survey: Asthma Control and Health Status	21
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	21
Novel Diagnostic Approaches for Eosinophilic Lung Diseases	21
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights	21
Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes	21
Biologics and Personalized Medicine in Severe Asthma: One Step at a Time	21
Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma	21
Delayed Skin Testing for Systemic Medications: Helpful or Not?	21
Some observations on systematic review of Phelan et al	20
Original Article Highlights From This Issue	20
Granulomatous Cheilitis Masquerading as Angioedema	20
Novel Strategies for Food Allergy Diagnosis	20
A New Year, A New Era in Drug Hypersensitivity—Looking Beyond the Classical Paradigms	20
Practice Notes	20
An Update in COVID-19 Vaccine Reactions in 2023: Progress and Understanding	20
Experience transitioning post–food allergy clinical trial participants to daily ingestion of retail food equivalents	20